Search

Venkataraman Balasubramanian

Examiner (ID: 8143, Phone: (571)272-0662 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1624, 1611
Total Applications
2999
Issued Applications
2024
Pending Applications
254
Abandoned Applications
724

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16681670 [patent_doc_number] => 10941136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-09 [patent_title] => Quinazoline derivative or its salt and pharmaceutical composition comprising the same [patent_app_type] => utility [patent_app_number] => 16/096712 [patent_app_country] => US [patent_app_date] => 2017-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11296 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096712 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/096712
Quinazoline derivative or its salt and pharmaceutical composition comprising the same Apr 25, 2017 Issued
Array ( [id] => 14273499 [patent_doc_number] => 20190134034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => Method of Treating Liver Cancer [patent_app_type] => utility [patent_app_number] => 16/094199 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4865 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094199 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/094199
Method of Treating Liver Cancer Apr 20, 2017 Abandoned
Array ( [id] => 11836231 [patent_doc_number] => 20170217949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => '4-ARYL-N-PHENYL-1,3,5-TRIAZIN-2-AMINES CONTAINING A SULFOXIMINE GROUP' [patent_app_type] => utility [patent_app_number] => 15/488155 [patent_app_country] => US [patent_app_date] => 2017-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67082 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488155 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/488155
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group Apr 13, 2017 Issued
Array ( [id] => 12158761 [patent_doc_number] => 20180030027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE' [patent_app_type] => utility [patent_app_number] => 15/485654 [patent_app_country] => US [patent_app_date] => 2017-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 126572 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15485654 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/485654
INHIBITORS OF BRUTON'S TYROSINE KINASE Apr 11, 2017 Abandoned
Array ( [id] => 11836189 [patent_doc_number] => 20170217908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => 'Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis' [patent_app_type] => utility [patent_app_number] => 15/484136 [patent_app_country] => US [patent_app_date] => 2017-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21781 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15484136 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/484136
Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis Apr 10, 2017 Abandoned
Array ( [id] => 11987724 [patent_doc_number] => 20170291880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-12 [patent_title] => 'PROCESS FOR THE PREPARATION OF TOLTRAZURIL AND AN INTERMEDIATE USEFUL FOR ITS PREPARATION' [patent_app_type] => utility [patent_app_number] => 15/480565 [patent_app_country] => US [patent_app_date] => 2017-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1141 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480565 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/480565
Process for the preparation of toltrazuril and an intermediate useful for its preparation Apr 5, 2017 Issued
Array ( [id] => 13106761 [patent_doc_number] => 10072013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-11 [patent_title] => Selective PI3K delta inhibitors [patent_app_type] => utility [patent_app_number] => 15/480128 [patent_app_country] => US [patent_app_date] => 2017-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 14134 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480128 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/480128
Selective PI3K delta inhibitors Apr 4, 2017 Issued
Array ( [id] => 14566739 [patent_doc_number] => 20190210976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => Compositions Of Crystallized Hydrophobic Compounds And Methods Of Making And Using Same [patent_app_type] => utility [patent_app_number] => 16/091330 [patent_app_country] => US [patent_app_date] => 2017-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22724 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091330 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/091330
Compositions of crystallized hydrophobic compounds and methods of making and using same Apr 3, 2017 Issued
Array ( [id] => 11757237 [patent_doc_number] => 20170204104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT' [patent_app_type] => utility [patent_app_number] => 15/479145 [patent_app_country] => US [patent_app_date] => 2017-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33893 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479145 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/479145
Compositions useful for treating disorders related to kit Apr 3, 2017 Issued
Array ( [id] => 14929791 [patent_doc_number] => 20190300533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => SUBSTITUTED PYRROLOPYRIMIDINE CDK INHIBITOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/087918 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11138 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087918 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/087918
Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof Mar 26, 2017 Issued
Array ( [id] => 11971137 [patent_doc_number] => 20170275290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/469975 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 107402 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469975 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/469975
Pyrrolotriazine compounds as tam inhibitors Mar 26, 2017 Issued
Array ( [id] => 14171663 [patent_doc_number] => 10259826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-16 [patent_title] => Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds [patent_app_type] => utility [patent_app_number] => 15/468467 [patent_app_country] => US [patent_app_date] => 2017-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 86985 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468467 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/468467
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds Mar 23, 2017 Issued
Array ( [id] => 16028113 [patent_doc_number] => 10676463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-09 [patent_title] => Monoglycidyl isocyanurate compound and production method therefor [patent_app_type] => utility [patent_app_number] => 16/091770 [patent_app_country] => US [patent_app_date] => 2017-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3581 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091770 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/091770
Monoglycidyl isocyanurate compound and production method therefor Mar 23, 2017 Issued
Array ( [id] => 11990434 [patent_doc_number] => 20170294589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-12 [patent_title] => 'COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/461914 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17310 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461914 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/461914
Compound and organic photoelectric device, image sensor and electronic device including the same Mar 16, 2017 Issued
Array ( [id] => 14317883 [patent_doc_number] => 20190148645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 16/088919 [patent_app_country] => US [patent_app_date] => 2017-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7881 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088919 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/088919
Organic electroluminescent compound and organic electroluminescent device comprising the same Mar 15, 2017 Issued
Array ( [id] => 14422467 [patent_doc_number] => 10316023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Therapeutic compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 15/449706 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20420 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449706 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/449706
Therapeutic compounds and uses thereof Mar 2, 2017 Issued
Array ( [id] => 14422467 [patent_doc_number] => 10316023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Therapeutic compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 15/449706 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20420 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449706 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/449706
Therapeutic compounds and uses thereof Mar 2, 2017 Issued
Array ( [id] => 14422467 [patent_doc_number] => 10316023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Therapeutic compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 15/449706 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20420 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449706 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/449706
Therapeutic compounds and uses thereof Mar 2, 2017 Issued
Array ( [id] => 14422467 [patent_doc_number] => 10316023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Therapeutic compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 15/449706 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20420 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449706 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/449706
Therapeutic compounds and uses thereof Mar 2, 2017 Issued
Array ( [id] => 11668413 [patent_doc_number] => 20170157133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'NOVEL PYRIDAZONES AND TRIAZINONES FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 15/432706 [patent_app_country] => US [patent_app_date] => 2017-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25531 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15432706 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/432706
Pyridazones and triazinones for treatment and prophylaxis of hepatitis B virus infection Feb 13, 2017 Issued
Menu